Page 1

Table of Contents ( Mark One ) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ΤΟ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K Delaware ( State or other jurisdiction of incorporation or organization ) Title of each class Common Commission File Number 001-37383 Arcadia Biosciences , Inc. ( Exact name of Registrant as specified in its Charter ) 202 Cousteau Place , Suite 105 Davis , CA ( Address of principal executive offices ) Large accelerated filer Non - accelerated filer ( 530 ) 756-7077 ( Registrant's Telephone Number , Including Area Code ) Securities registered pursuant to Section 12 ( b ) of the Act : Trading Symbol ( s ) RKDA NO É Securities registered pursuant to Section 12 ( g ) of the Act : None Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . YES □ Indicate by check mark if the registrant is not required to file reports pursuant to Section or 15 ( d ) of the Act . YES □ NO > Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the Registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . YES > NO ☐ ☐ ☐ ☐ 81-0571538 ( I.R.S. Employer Identification No. ) 95618 ( Zip Code ) Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the Registrant was required to submit such files ) . YES NO O Name of each exchange on which registered NASDAQ CAPITAL MARKET Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer , " " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Accelerated filer Smaller reporting company Emerging growth company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . □ Indicate by check mark whether the Registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) . YES □ NO É 风口 The aggregate market value of the voting and non - voting common equity held by non - affiliates of the Registrant as of June 30 , 2020 , the last business day of the Registrant's most recently completed second fiscal quarter , was approximately $ 33,300,000 ( based on the closing price of $ 3.76 on June 30 , 2020 on the NASDAQ Capital Market ) . The number of shares outstanding of the Registrant's common stock on March 19 , 2021 , was 21,336,249 shares . DOCUMENTS INCORPORATED BY REFERENCE Information required by Part III of this Annual Report on Form 10 - K is incorporated by reference to the Registrant's Definitive Proxy Statement for its 2021 Annual Meeting of Stockholders , which proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Form 10 K.